Hepatocellular Carcinoma
New evidence disfavors tamoxifen for primary liver cancer
Published in Hepatitis Weekly, December 2nd, 2002
Although some HCCs carry estrogen receptors, the vast majority do not. Tamoxifen, an estrogen competitor, is best known for the prevention and treatment of breast cancer. Some studies of tamoxifen in HCC have yielded contradictory results. Now, new evidence from an Asian multicenter trial of high-dose tamoxifen in people with inoperable HCC should clear up some of the confusion.
During the trial, 329...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-12-02)
More Articles from Hepatitis Weekly
- Chronic Hepatitis B Therapy
Interleukin-12 restores antigen-specific response to hepatitis B virus - Thrombocytopenia
Platelet levels reversible in hepatitis C patients on consensus interferon - Endostatin
Antiangiogenic protein is tumor marker in hepatocellular carcinoma - Hepatitis C Risk Factors
High prevalence of hepatitis C virus detected among spinal cord injured - Interferon Risk Factors
Therapy okay for chronic hepatitis C patients with constitutional neutropenia - AIDS Therapy
FDA accepts Coviracil NDA for the treatment of HIV - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
